AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
IBESARTAN
12 registrations across 2 African markets— 12 active
Markets with IBESARTAN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| APROVEL TABLETS (Each tablet contains Ibesartan 150mg) | 🇬🇭Ghana | — | active | Sept 2029 |
| APROVEL TABLETS (Each tablet contains Ibesartan 150mg) | 🇬🇭Ghana | — | active | Sept 2029 |
| APROVEL TABLETS (Each tablet contains Ibesartan 300mg) | 🇬🇭Ghana | — | active | Sept 2027 |
| APROVEL TABLETS (Each tablet contains Ibesartan 300mg) | 🇬🇭Ghana | — | active | Sept 2027 |
| APROVEL TABLETS (Each tablet contains Ibesartan 150mg) | 🇬🇭Ghana | — | active | Sept 2027 |
| APROVEL TABLETS (Each tablet contains Ibesartan 150mg) | 🇬🇭Ghana | — | active | Sept 2027 |
| Vepran comprimé pelliculé / 300 mg | 🇸🇳Senegal | — | active | — |
| IRBESARTAN GRB comprimé pelliculé / 75 mg | 🇸🇳Senegal | BIOGARAN | active | — |
| Vepran comprimé pelliculé / 150 mg | 🇸🇳Senegal | — | active | — |
| IRBESARTAN GRB comprimé pelliculé / 75 mg | 🇸🇳Senegal | BIOGARAN | active | — |
| Vepran comprimé pelliculé / 300 mg | 🇸🇳Senegal | — | active | — |
| Vepran comprimé pelliculé / 150 mg | 🇸🇳Senegal | — | active | — |
IBESARTAN in Africa — Regulatory Overview
IBESARTAN is registered across 2 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Senegal. AfricaRegulatory refreshes this data daily from official government sources.
Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.